Compare ARQT & HOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARQT | HOG |
|---|---|---|
| Founded | 2016 | 1903 |
| Country | United States | United States |
| Employees | N/A | 6400 |
| Industry | Biotechnology: Pharmaceutical Preparations | Motor Vehicles |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.5B |
| IPO Year | 2020 | 1994 |
| Metric | ARQT | HOG |
|---|---|---|
| Price | $23.69 | $25.16 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 7 |
| Target Price | ★ $34.00 | $24.00 |
| AVG Volume (30 Days) | 1.7M | ★ 2.0M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 3.05% |
| EPS Growth | ★ 88.79 | N/A |
| EPS | N/A | ★ 0.22 |
| Revenue | $376,072,000.00 | ★ $4,473,175,000.00 |
| Revenue This Year | $34.85 | N/A |
| Revenue Next Year | $29.39 | $3.79 |
| P/E Ratio | ★ N/A | $115.84 |
| Revenue Growth | ★ 91.34 | N/A |
| 52 Week Low | $12.72 | $17.09 |
| 52 Week High | $31.77 | $31.25 |
| Indicator | ARQT | HOG |
|---|---|---|
| Relative Strength Index (RSI) | 62.23 | 58.02 |
| Support Level | $22.41 | $24.34 |
| Resistance Level | $23.87 | $26.99 |
| Average True Range (ATR) | 0.85 | 0.80 |
| MACD | 0.34 | 0.04 |
| Stochastic Oscillator | 91.83 | 78.74 |
Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.
Harley-Davidson is a leading global manufacturer of heavyweight motorcycles across the custom, cruising, and touring categories, as well as related merchandise, parts, and accessories. In recent years, the firm has expanded into the adventure touring market with its Pan America model, into electric with the LiveWire brand, and is returning to smaller-displacement bikes with the Sprint. Its captive finance arm, Harley-Davidson Financial Services, provides wholesale financing to dealers and retail financing and insurance brokerage services to customers. Harley captured around 34% of the heavyweight domestic market in 2025.